IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS - ANVISA Registration 10337990045

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10337990045 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD. The registration is held by LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA. with validity until Nov 23, 2030.

This page provides complete technical specifications for 2 related devices, regulatory compliance details. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.